Andrew Kruse, PhD
Dr. Kruse is Assistant Professor of Biological Chemistry and Molecular Pharmacology at Harvard Medical School. In 2016, Andrew’s group published in Nature the first crystal structure of Sigma1. His research focuses on the molecular basis of transmembrane signaling through pharmacology and structural biology. This work was recently described as a “landmark achievement for molecular pharmacology and drug discovery” (F1000Prime review by Bryan Roth, UNC Chapel Hill). Andrew has received multiple prestigious awards, including the Sloan Research Fellowship (2017), Forbes 30 under 30 (2016), and the NIH Director’s Early Independence Award (2015). He holds bachelor’s degrees in Biochemistry and Mathematics from the University of Minnesota and a PhD in Structural Biology from Stanford University.